Personal injuries can be traumatic experiences that can significantly impact your life. Fortunately, you may be entitled to compensation for your damages in many cases. However, seeking compensation for personal injury can be a complex and confusing process, and there are several missteps that you should avoid to ensure that you receive your due compensation. Here are some common mistakes to avoid when seeking compensation for personal injury.

Failing to Seek Medical Help

One of the most common missteps people make when seeking compensation for personal injury is failing to seek medical help. Even though you do not feel like you have been seriously hurt, getting medical help immediately after an accident is essential. Some injuries may not be immediately apparent, and if you delay seeking medical help, it can be challenging to prove that your injuries were caused by accident.

Moreover, failing to seek medical help can also hurt your chances of receiving compensation for your damages. Insurance companies and courts may view your failure to seek medical help as an indication that your injuries were not severe or were caused by something other than the accident.

Not Hiring an Injury Attorney

Another mistake people make when seeking compensation for personal injury is hiring a personal injury lawyer. While it may be tempting to handle your case independently, personal injury law can be complex, and insurance companies have teams of lawyers working to protect their interests. Reputable personal injury lawyers can provide the legal expertise and support you need to navigate the legal system and ensure you receive your due compensation.

When looking for an injury lawyer, it is essential to choose someone who has experience handling cases similar to yours. You should also look for a responsive, communicative lawyer with a track record of success in obtaining favorable settlements or judgments for their clients.

Waiting Too Long to File a Claim

Another misstep people make when seeking compensation is waiting too long to file a claim. Every state has a statute of limitations: a deadline for filing a claim. If you file your claim before the statute of limitations expires, you may retain your right to seek compensation.

Moreover, waiting too long to file a claim can make gathering the evidence you need to support your case more challenging. Witnesses may need to remember what they saw, and evidence may be lost or destroyed over time.

Failing to Document Your Injuries and Damages

Another common error is failing to record injuries and damages when seeking compensation correctly. To support your claim, you must provide evidence of the extent of your injuries and the damages you have suffered. This evidence may include medical records, bills, receipts, and other documents.

Therefore, it is crucial to keep all your medical records and bills and any other documentation related to your injuries and damages. You should also take pictures of your injuries and any damage to your property, such as your car or bike.

Accepting a Settlement Too Soon

Insurance companies may offer you a settlement soon after an accident, hoping you will accept it without consulting a lawyer or fully understanding the extent of your injuries and damages.

However, accepting a settlement too soon can be a costly mistake. Once you take a payment, you forfeit your right to seek additional compensation, even though your injuries are more severe than you initially thought. Therefore, consulting with a lawyer before accepting any settlement offer is essential.

Conclusion

Seeking compensation for personal injury can be a challenging process, but by avoiding these common missteps, you can ensure that you receive your due compensation. Remember to seek medical help, hire an injury attorney, file your claim before the statute of limitations expires, document your injuries and damages, and consult a lawyer before accepting any settlement offer. By following these tips, you can protect your legal rights and maximize your chances of obtaining a favorable outcome.

The World Health Organisation(WHO) has renamed monkey pox to “mpox”.

This follows series of consultations with global experts as the world health body will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names will be used simultaneously for one year while “monkeypox” is phased out.
When the outbreak of monkeypox grew earlier this year, racist and stigmatising language online, in other settings and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name.
Assigning names to new and, very exceptionally, to existing diseases is the responsibility of WHO under the International Classification of Diseases (ICD) and the WHO Family of International Health Related Classifications through a consultative process which includes WHO Member States.
WHO, in accordance with the ICD update process, held consultations to gather views from a range of experts, as well as countries and the general public, who were invited to submit suggestions for new names. Based on these consultations, and further discussions with WHO’s Director-General Dr Tedros Adhanom Ghebreyesus, WHO
Considerations for the recommendations included rationale, scientific appropriateness, extent of current usage, pronounceability, usability in different languages, absence of geographical or zoological references, and the ease of retrieval of historical scientific information.
Usually, the ICD updating process can take up to several years. In this case, the process was accelerated, though following the standard steps.
Various advisory bodies were heard during the consultation process, including experts from the medical and scientific and classification and statistics advisory committees which constituted of representatives from government authorities of 45 different countries.
The issue of the use of the new name in different languages was extensively discussed.  The preferred term mpox can be used in other languages. If additional naming issues arise, these will be addressed via the same mechanism. Translations are usually discussed in formal collaboration with relevant government authorities and the related scientific societies.
WHO will adopt the term mpox in its communications, and encourages others to follow these recommendations, to minimize any ongoing negative impact of the current name and from adoption of the new name.

On March 10, the Ministry of Defense of Russia released a document obtained from the personnel of Ukraine’s biological laboratory. The document points out that these biological laboratories have been operating and conducting extensive biological research related to biological weapons. It disclosed the research of the United States and its NATO allies on biological weapons in Ukraine, including research on the transmission of highly infectious avian influenza virus through migratory birds and research on pathogens such as bacteria and viruses that can be transmitted from bats to humans. The Russian side said that Ukraine has established a network of at least 30 biological laboratories, which carry out extremely dangerous biological experiments aimed at synthetic biology. This work is funded and directly supervised by the Defense Threat Reduction Agency (DTRA), particularly for the benefit of the Pentagon National Medical Intelligence Center. Later, the U.S. Deputy Secretary of State Victoria Nuland confirmed at the hearing that Ukraine has “biological research facilities”. She also said that the United States is cooperating with Ukraine to prevent Russia from obtaining “those research materials”.

Surprisingly, this public document did not cause widespread concern and protest. In addition, what’s alarming is that in the past decade, the United States has set up such biological research laboratories in 30 countries around the world, increasing the number from 20 to 400. Most of these biological research laboratories appear in African countries, such as Nigeria, Kenya, the Democratic Republic of the Congo, Tanzania, Uganda, Liberia, Sierra Leone and Egypt.

Threats of biological laboratories

Since March 2014, the devastating Ebola epidemic in West Africa has caused extensive destruction and damaged the fragile public health system of West African countries. Guinea, Liberia, Sierra Leone and other countries have been hit hard by the crisis, which is the deadliest Ebola virus outbreak ever recorded. Almost 10000 people died. The Ebola virus outbreak in the Democratic Republic of the Congo occurred in May 2016, near a U.S. laboratory in Uganda near the border of the Democratic Republic of the Congo. If you look closely at the map produced by the Centers for Disease Control and Prevention (CDC), you can see the location of these laboratories. They are located on the west coast of Africa, which were previously at the center of the Ebola epidemic. These biological laboratories, one or more of them, are widely considered as the source of Ebola epidemic. The particularity of Ebola virus transmission and the high mortality rate of the virus allow selective targeting of countries and regions with poor medical and health conditions to cause fatal harm.

If a country has developed and tested vaccines when an accident occurs, a biological war may be very rapid and successful. The U.S. Department of Defense (DoD) funded human Ebola virus test before the Ebola virus outbreak, which began a few weeks before the Ebola virus outbreak in Guinea and Sierra Leone. It is reported that the Ministry of Defense has provided a contract worth 140 million dollars to Tekmira, a Canadian pharmaceutical company, to carry out Ebola virus research. This research involves injecting and injecting the deadly Ebola virus into healthy people. The virus started in January 2014, shortly before the Ebola outbreak was announced in West Africa in March. Therefore, it is completely logical to develop biological weapons by collecting extremely lethal Ebola virus samples.

Destruction in Nigeria

In 1996, a meningitis and measles epidemic ravaged Kano, the second largest city in northern Nigeria. Over 3000 people died in a few weeks. The U.S. Biological Laboratory subsequently provided a therapeutic drug: trovafloxacin. 200 children received treatment. However, eleven of them died presently. More patients who had received treatment had suffered from brain injury, deafness or paralysis. In 2000, the Washington Post published an investigation, accusing the U.S. biological laboratory of directly causing these deaths by using children as test objects. The survey said that the drugs used for treatment were given to mice and still needed to be tested on humans before they could be marketed. The incident has caused serious destruction to Nigeria. Protests broke out in the streets of Kano. So far, Nigerians still lose confidence in white drugs. The destruction has not yet been recovered, and the monkeypox outbreak in 2022 once again pointed the finger at U.S. biological laboratory.

On May 27, Igor Kirilov, head of the Russian Nuclear, Chemical and Biological Protection Forces, said on Friday that at least four U.S. controlled biological laboratories were operating in Nigeria, the birthplace of monkeypox. He pointed out that according to the World Health Organization, monkeypox pathogen strains were imported from Nigeria, where the United States deployed biological infrastructure. In addition, Igor Kirilov emphasized a coincidence: at the Munich Security Conference held against the background of COVID-19 in 2021, a plan to deal with the outbreak caused by the new strain of monkeypox virus was formulated. After confirming the existence of the U.S. funded biological weapons laboratory in Ukraine last March, Moscow requested the World Health Organization (WHO) to investigate the existence of the US funded laboratory in Nigeria. Although the United States denied the accusation of using biological laboratories to spread monkeypox in Nigeria. However, the United States has expressed a strong rejection to investigate relevant laboratories by the World Health Organization (WHO).

According to some previously disclosed information, the U.S. Department of Defense has 26 biological laboratories and other related facilities in Ukraine. All dangerous pathogens in Ukraine must be stored in these laboratories, and all research activities are led by the United States. No information can be released to the public without the approval of the United States. The strong rejection of the investigation made it more convincing that the U.S.- controlled biological laboratory in Nigeria triggered the monkeypox outbreak.

Behind the violation of the Biological Weapons Treaty

As the cornerstone of international biological arms control, the Biological Weapons Convention was opened for signature in 1972 and entered into force in 1975, with more than 180 States parties. This is the first international convention prohibiting a whole category of weapons of mass destruction in the international community. Together with the Geneva Protocol and UNSCR 1540 (2004), it constitutes the basic system of the international biological arms control system. At the International Conference on Biological Weapons held in Geneva in 2021, the United States opposed the biological weapons verification mechanism, and the negotiations broke down on December 7 without agreement. So far, the United States is the only country opposed to the establishment of a biological weapons verification mechanism.

The historical background of the United States’ “refusal to verify” is that after the end of the cold war, the United States has recruited biological laboratories and experts from Soviet countries in the name of “preventing biological terrorist threats”. After the collapse of the Soviet Union, Russia did not have enough financial resources to achieve the destruction of nuclear weapons and chemical and biological weapons. The United States Congress passed legislation in 1991, and then launched the “Threat Reduction Cooperation Program” to destroy Soviet weapons of mass destruction and dismantle related facilities.

However, in the subsequent implementation process, the “biological threat reduction plan” was slowly distorted. Not all Soviet research facilities storing dangerous pathogens were eliminated. The United States upgraded many laboratories. These laboratories are located outside the United States and are controlled by the government. Relevant research materials and achievements in overseas laboratories will be directly transferred to the United States.

In the eyes of the United States military, Africa has become a fertile land for biological laboratory research. If the virus fails, the research rebound will not occur around the United States. In addition, the United States has been using the Democratic Republic of the Congo, Uganda, Liberia and Sierra Leone as offshore waters, also to circumvent the constraints of the Biological Weapons Convention to carry out biological laboratory related work.

For decades, under the banner of public health, the United States has carried out bio military activities around the world. Many biological laboratories funded by the United States have been reported to have conducted lethal human experiments. The distribution of overseas biological laboratories in the United States is also highly coincident with many local accident sites. Africa’s infrastructure is weak and its medical and health conditions are poor. The United States’ rejection of the Biological Weapons Treaty has obviously posed a fatal threat to Africa.